Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Escin-iib
1. Aescin
2. 26339-90-2
3. Escini B
4. Beta-escin
5. Chebi:2500
6. Qyk0d6h79o
7. Flogencyl
8. Beta-aescin
9. Aescin Ib
10. Aescin B
11. .beta.-escin
12. Aescin Ib(sh)
13. 6805-41-0
14. Unii-qyk0d6h79o
15. Escine Ib
16. Escin-ib
17. Escinib
18. Nsc-758653
19. Aescine (dcf)
20. Einecs 247-619-4
21. Reparil (tn)
22. .beta.-aescin
23. .beta.-escin [mi]
24. Chembl505939
25. Dtxsid601026279
26. Escin .beta.-escin [mi]
27. Hy-n0555
28. Bdbm50466108
29. Mfcd10566622
30. Beta-d-glucopyranosiduronic Acid, (3beta,16alpha,21beta(z),22alpha)-22-(acetyloxy)-16,24,28-trihydroxy-21-((2-methyl-1-oxo-2-butenyl)oxy)olean-12-en-3-yl O-beta-d-glucopyranosyl-(1.2)-o-(beta-d-glucopyranosyl-(1.4))-
31. Cs-0009082
32. N2164
33. C08921
34. D07912
35. 339e902
36. Q27895506
37. Escin Ib (constituent Of Horse Chestnut) [dsc]
38. .beta.-d-glucopyranosiduronic Acid, (3.beta.,4.beta.,16.alpha.,21.beta.,22.alpha.)-22-(acetyloxy)-16,23,28-trihydroxy-21-(((2z)-2-methyl-1-oxo-2-buten-1-yl)oxy)olean-12-en-3-yl O-.beta.-d-glucopyranosyl-(1->2)-o-(.beta.-d-glucopyranosyl-(1->4))-
39. 2-butenoic Acid, 2-methyl-, (3.beta.,4.beta.,16.alpha.,21.beta.,22.alpha.)-22-(acetyloxy)-3-[[o-.beta.-d-glucopyranosyl-(1->2)-o-[.beta.-d-glucopyranosyl-(1->4)]-.beta.-d-glucopyranuronosyl]oxy]-16,23,28-trihydroxyolean-12-en-21-yl Ester, (2z)-
| Molecular Weight | 1131.3 g/mol |
|---|---|
| Molecular Formula | C55H86O24 |
| XLogP3 | 0.7 |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 24 |
| Rotatable Bond Count | 16 |
| Exact Mass | 1130.55090361 g/mol |
| Monoisotopic Mass | 1130.55090361 g/mol |
| Topological Polar Surface Area | 388 Ų |
| Heavy Atom Count | 79 |
| Formal Charge | 0 |
| Complexity | 2300 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 27 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
18
PharmaCompass offers a list of Aescin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aescin manufacturer or Aescin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aescin manufacturer or Aescin supplier.
PharmaCompass also assists you with knowing the Aescin API Price utilized in the formulation of products. Aescin API Price is not always fixed or binding as the Aescin Price is obtained through a variety of data sources. The Aescin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A .BETA.-ESCIN [MI] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of .BETA.-ESCIN [MI], including repackagers and relabelers. The FDA regulates .BETA.-ESCIN [MI] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. .BETA.-ESCIN [MI] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of .BETA.-ESCIN [MI] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A .BETA.-ESCIN [MI] supplier is an individual or a company that provides .BETA.-ESCIN [MI] active pharmaceutical ingredient (API) or .BETA.-ESCIN [MI] finished formulations upon request. The .BETA.-ESCIN [MI] suppliers may include .BETA.-ESCIN [MI] API manufacturers, exporters, distributors and traders.
click here to find a list of .BETA.-ESCIN [MI] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
.BETA.-ESCIN [MI] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of .BETA.-ESCIN [MI] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right .BETA.-ESCIN [MI] GMP manufacturer or .BETA.-ESCIN [MI] GMP API supplier for your needs.
A .BETA.-ESCIN [MI] CoA (Certificate of Analysis) is a formal document that attests to .BETA.-ESCIN [MI]'s compliance with .BETA.-ESCIN [MI] specifications and serves as a tool for batch-level quality control.
.BETA.-ESCIN [MI] CoA mostly includes findings from lab analyses of a specific batch. For each .BETA.-ESCIN [MI] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
.BETA.-ESCIN [MI] may be tested according to a variety of international standards, such as European Pharmacopoeia (.BETA.-ESCIN [MI] EP), .BETA.-ESCIN [MI] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (.BETA.-ESCIN [MI] USP).
